# Supreme Court Allows Abortion Pill Access by Mail to Continue
The Supreme Court has blocked a lower court ruling that would have severely limited access to mifepristone, the medication used in medication abortion. The decision preserves the ability of patients to receive abortion pills by mail, a practice that has expanded access since the FDA loosened restrictions in 2023.
A federal appeals court had sided with anti-abortion groups challenging the FDA's approval of mifepristone. That ruling would have required patients to obtain the drug in person at clinics or hospitals, effectively eliminating mail delivery of the medication across the country.
The Supreme Court's intervention maintains the current regulatory framework. Under FDA guidelines updated in 2023, mifepristone can be dispensed by mail through certified pharmacies after a telehealth consultation with a healthcare provider. This expansion came after the agency determined the pill has a strong safety record across decades of use.
Mail access to mifepristone has become particularly important for patients in states with abortion restrictions or limited clinic availability. Research shows medication abortion accounts for more than half of all abortions in the United States, with mail access enabling patients in rural or restrictive states to access care without traveling.
The ruling does not resolve underlying legal challenges to mifepristone's approval. Conservative states and groups have filed multiple cases arguing the FDA's original 2000 approval was improper. The Supreme Court's decision to maintain current access rules suggests the justices were unwilling to overturn established FDA authority during ongoing litigation.
Healthcare providers have emphasized the safety record supporting mail access. Serious complications from medication abortion remain rare, occurring in less than 1 percent of cases. The decision reflects growing recognition that restricting access to FDA-approved medications raises both legal and public health questions.
The ruling affects millions of Americans. Roughly 60 percent of medication abortions now involve m